ImageVerifierCode 换一换
格式:PDF , 页数:5 ,大小:151.11KB ,
资源ID:536335      下载积分:5000 积分
快捷下载
登录下载
邮箱/手机:
温馨提示:
如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝扫码支付 微信扫码支付   
注意:如需开发票,请勿充值!
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【http://www.mydoc123.com/d-536335.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(ASTM F2026-2016 Standard Specification for Polyetheretherketone (PEEK) Polymers for Surgical Implant Applications《外科植入物应用的聚醚醚酮 (PEEK) 聚合物的标准规格》.pdf)为本站会员(medalangle361)主动上传,麦多课文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文库(发送邮件至master@mydoc123.com或直接QQ联系客服),我们立即给予删除!

ASTM F2026-2016 Standard Specification for Polyetheretherketone (PEEK) Polymers for Surgical Implant Applications《外科植入物应用的聚醚醚酮 (PEEK) 聚合物的标准规格》.pdf

1、Designation: F2026 14F2026 16Standard Specification forPolyetheretherketone (PEEK) Polymers for Surgical ImplantApplications1This standard is issued under the fixed designation F2026; the number immediately following the designation indicates the year oforiginal adoption or, in the case of revision,

2、 the year of last revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon () indicates an editorial change since the last revision or reapproval.1. Scope1.1 This specification covers polyetheretherketone (PEEK) polymer in virgin forms as supplied by a vendor (pe

3、llets, powder,fabricated forms, and so forth). It provides requirements and associated test methods for these thermoplastics when they are to beused in the manufacture of intracorporeal devices such as surgical implants or components of surgical or dental devices.1.2 The properties included in this

4、specification are those applicable for PEEK polymers only. Indicated properties are forfabricated forms. Materials or forms containing colorants, fillers, processing aids, or other additives, as well as polymer blendswhich contain PEEK, or reclaimed materials, are not covered by this specification.1

5、.3 This specification is designed to recommend physical, chemical, and biological test methods to establish a reasonable levelof confidence concerning the performance of virgin PEEK polymers for use in medical implant devices.1.4 The values stated in SI units are to be regarded as standard. No other

6、 units of measurement are included in this standard.1.5 When evaluating material in accordance with this specification, hazardous materials, operations, and equipment may beinvolved. This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the resp

7、onsibilityof the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatorylimitations prior to use.2. Referenced Documents2.1 ASTM Standards:2D256 Test Methods for Determining the Izod Pendulum Impact Resistance of PlasticsD638 Test Meth

8、od for Tensile Properties of PlasticsD648 Test Method for Deflection Temperature of Plastics Under Flexural Load in the Edgewise PositionD695 Test Method for Compressive Properties of Rigid PlasticsD790 Test Methods for Flexural Properties of Unreinforced and Reinforced Plastics and Electrical Insul

9、ating MaterialsD792 Test Methods for Density and Specific Gravity (Relative Density) of Plastics by DisplacementD1505 Test Method for Density of Plastics by the Density-Gradient TechniqueD3418 Test Method for Transition Temperatures and Enthalpies of Fusion and Crystallization of Polymers by Differe

10、ntialScanning CalorimetryD4000 Classification System for Specifying Plastic MaterialsF748 Practice for Selecting Generic Biological Test Methods for Materials and Devices2.2 ISO Standards:3ISO 178 PlasticsDetermination of Flexural PropertiesISO 180 PlasticsDetermination of Izod Impact StrengthISO 52

11、7 PlasticsDetermination of Tensile PropertiesPart 1: General PrinciplesISO 1183 PlasticsMethods for Determining the Density of Non-cellular PlasticsPart 2: Density Gradient Column MethodISO 10993 Biological Evaluation of Medical Devices, Parts 1-12ISO 13485 Medical DevicesQuality Management SystemsR

12、equirements for Regulatory Purposes1 This specification is under the jurisdiction of ASTM Committee F04 on Medical and Surgical Materials and Devices and is the direct responsibility of SubcommitteeF04.11 on Polymeric Materials.Current edition approved March 1, 2014April 1, 2016. Published May 2014M

13、ay 2016. Originally approved in 2000. Last previous edition approved in 20122014 asF2026 12.F2026 14. DOI: 10.1520/F2026-14.10.1520/F2026-16.2 For referencedASTM standards, visit theASTM website, www.astm.org, or contactASTM Customer Service at serviceastm.org. For Annual Book of ASTM Standardsvolum

14、e information, refer to the standards Document Summary page on the ASTM website.3 Available from American National Standards Institute (ANSI), 25 W. 43rd St., 4th Floor, New York, NY 10036, http:/www.ansi.org.This document is not an ASTM standard and is intended only to provide the user of an ASTM s

15、tandard an indication of what changes have been made to the previous version. Becauseit may not be technically possible to adequately depict all changes accurately, ASTM recommends that users consult prior editions as appropriate. In all cases only the current versionof the standard as published by

16、ASTM is to be considered the official document.Copyright ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States12.3 Other Documents:United States Pharmacopeia, Vol. XXI, or latest edition43. Terminology3.1 Definitions of Terms Specific to This Standar

17、d:3.1.1 fabricated forms, nthose items into which the virgin forms may be converted. These include shapes and forms producedby means of machining, extruding, and compression molding virgin forms into a subsequent entity (for example, fibers, tubes, rods,slabs, sheets, film, or complex shaped parts a

18、nd devices).3.1.2 formulated compound, nmaterials, parts, or devices fabricated from virgin forms in such a way as to contain intentionalor unintentional adjuvant substances.3.1.3 virgin forms, nthe initially delivered form of the polymer as synthesized from its monomers prior to any processing orfa

19、brication into a medical device. The provided resin is typically in the form of pellets, granules, or powder and is the materialfrom which fibers, tubes, rods, slabs, sheets, films, or specific parts and devices are fabricated.4. Classification4.1 The PEEK polymer in the scope of this specification

20、is a pure semicrystalline homopolymer consisting of phenylene ringsconnected by ether (E) and carbonyl (or ketone, K) groups along the polymer chain (see Appendix X1). Its polymeric structureis defined by the repeating unit EEK.4.2 Types of PEEK plastics, molding, and extrusion grades are described

21、in Classification System D4000.5. Properties5.1 The properties listed below shall be considered in selecting material(s) in accordance with the specific end-use requirements.5.2 The infrared spectrum5 of these materials is characteristic of their molecular repeating units. A representative spectrum

22、islisted in Appendix X3. The PEEK polymer shall yield an infrared spectrum, which exhibits major bands only at the wavelengthslisted for a standard reference spectrum of that material.5.2.1 The infrared spectrum, as used in this specification, is to identify the specific type of poly aryl ether keto

23、ne (PAEK) presentand does not necessarily indicate an acceptable degree of material purity.5.2.2 The presence of additional bands in the samples infrared spectrum compared to that of the reference material may indicatea different PAEK or impurities, or both.5.3 The physical and chemical property req

24、uirements for the virgin polymer are listed in Table 1. If additional characteristicsare necessary because of a specific application, the procedures referenced in Section 2 are recommended, or as agreed uponbetween the vendor and the purchaser.4 Available from U.S. Pharmacopeia (USP), 12601 Twinbroo

25、k Pkwy., Rockville, MD 20852-1790, http:/www.usp.org.5 Silverstein, R. M., Bassler, G. C., and Morrill, T. C., Spectroscopic Identification of Organic Compounds, 5th ed., John Wiley polyetheretherketoneAPPENDIXES6 Hay, J. N., and Kemmish, D. J., “Environmental Stress Crack Resistance and Absorption

26、of Low-Molecular-Weight Penetrants by Poly(Aryl Ether Ether Ketone),”Polymer, Vol 29, April 1988, pp. 613618.7 Srivastava, A. P., Depke, N., and Wolf, C. J., “Environmental Stress Deformation of Poly(ether ether ketone),” J. Applied Polymer Science, Vol 66, 1997, pp. 725731.8 Kurtz, S.M. and Devine,

27、 J.N., “PEEK Biomaterials in Trauma, Orthopedic, and Spinal Implants,” Biomaterials, Vol 28, No. 32, 2007, pp. 4845-4869.TABLE 2 Required Properties of Fabricated FormsParameter ISO Methods and Requirements ASTM Methods and RequirementsDensity, kg/m3 ISO 1183 1280 - 1320 ASTM D792 orASTM D15051280 -

28、 1320Tensile Strength: ISO 527, Type 1B,50 mm/minASTM D638,Type IV, 5.08 cm/minat yield (zero slope), min, MPa 90 90at break, min, MPa 70 70Elongation at break,A min, % ISO 527, Type 1B,50 mm/min5 ASTM D638,Type IV, 5.08 cm/min5Flexural strength, min, MPa ISO 178 110 ASTM D790 110Flexural modulus, m

29、in, GPa ISO 178 3 ASTM D790 3Impact strength,notched Izod, minISO 180 4 (kJ/m2) ASTM D256, 0.254 cm depth,0.025 cm radius50 (J/m)A Use an extensometer for measuring strain and calculating percent elongation.F2026 163(Nonmandatory Information)X1. RATIONALEX1.1 The PEEK polymers may be processed by mo

30、st techniques available for thermoplastic polymers. Medical devices andcomponents of medical devices made of PEEK polymers may be sterilized. Sterilization methods successfully used include steam,ethylene oxide, and irradiation. Repeated sterilization may weaken parts fabricated of any plastic mater

31、ial. The number of timesa given part may be sterilized safely without fear of subsequent failure depends on a number of factors including the molecularweight of the polymer and design, fabrication, intended function, and method of sterilization of the device. Therefore, it isimperative that the manu

32、facturer test the device in order to determine the maximum number of sterilization cycles to which it canbe safely subjected.X1.2 The potential to develop a significant level of crystallinity is an important characteristic of these materials. Performancecharacteristics are related to the percent cry

33、stallinity. Certain additives and processes (for example, excessive cross linking) canlimit these materials ability to crystallize. Therefore, this feature of the polymer and its fabricated form should be evaluated, usingappropriate test methods, to ensure efficacy.X1.3 A formulated compound or fabr

34、icated part or device may contain optional adjuvant substances required for the fabricationor intended use of the end product. The biocompatibility of these adjuvant substances, and subsequent formulated compounds,parts, and devices shall be established in accordance with Practice F748 or the ISO 10

35、993 series.X2. CHEMICAL STRUCTURE OF PEEKX3. REPRESENTATIVE INFRARED SPECTRA OF PEEKF2026 164RELATED MATERIALAutian, J., “Toxicological Evaluation of Biomaterials: Primary Acute Toxicity Screening Program,” Journal of Artificial Organs, Vol 1, No. 1, 1977,p. 53.Autian, J., “The New Field of Plastic

36、Toxicological Methods and Results,” CRC Critics Review in Toxicology, 1973, p. 18.Homsy, C. A., Ansevin, K. D., OBrannon, W., Thompson, S. H., Hodge, R., and Estrella, M. E., “Rapid In Vitro Screening of Polymers forBiocompatibility,” Journal of Macromolecular Science Chemistry, Vol A4, No. 3, May 1

37、970, pp. 615-634.Rice, R. M., Hegyeli, A. F., Gourlay, S. J., Wade, C. W. R., Dillon, J. G., Jaffe, H., and Kulkarni, R. K., “Biocompatibility Testing for Polymers: InVitro Studies With In Vivo Correlation,” Journal of Biomedical Materials Research, Vol 12, 1978, p. 43.ASTM International takes no po

38、sition respecting the validity of any patent rights asserted in connection with any item mentionedin this standard. Users of this standard are expressly advised that determination of the validity of any such patent rights, and the riskof infringement of such rights, are entirely their own responsibi

39、lity.This standard is subject to revision at any time by the responsible technical committee and must be reviewed every five years andif not revised, either reapproved or withdrawn.Your comments are invited either for revision of this standard or for additional standardsand should be addressed to AS

40、TM International Headquarters. Your comments will receive careful consideration at a meeting of theresponsible technical committee, which you may attend. If you feel that your comments have not received a fair hearing you shouldmake your views known to the ASTM Committee on Standards, at the address

41、 shown below.This standard is copyrighted by ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959,United States. Individual reprints (single or multiple copies) of this standard may be obtained by contacting ASTM at the aboveaddress or at 610-832-9585 (phone), 610-832-9555 (fax), or serviceastm.org (e-mail); or through the ASTM website(www.astm.org). Permission rights to photocopy the standard may also be secured from the Copyright Clearance Center, 222Rosewood Drive, Danvers, MA 01923, Tel: (978) 646-2600; http:/ 165

copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
备案/许可证编号:苏ICP备17064731号-1